Skip to content

PHLEBOCARE

Active Risk: not assessed Private limited companyfounded 2026active for less than a yearKeizer Karellaan 187, 1083 GanshorenKBO/BCE: BE 1033.905.083
PHLEBOCARE
Follow ReportCompare

Board

2 directors, since incorporation
Director
appointed by deed of 05-02-2026
Director
appointed by deed of 05-02-2026

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today

Director

Director
Board
Mandates as a list
    • Director, appointed by deed of 05-02-2026, still in office
    • Director, appointed by deed of 05-02-2026, still in office

Control

Founders
,
This company
PHLEBOCARE

Capital

Contribution
€10,000
Shares
100
Contribution per share
€100
Source
deed of 05-02-2026

Articles of association

deed of 05-02-2026 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 January to 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
16 February at 16:00

Shareholders

At incorporation deed of 05-02-2026 ↗
  • 50 shares (50%) · €5,000 in cash
  • 50 shares (50%) · €5,000 in cash

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure